ClinicalTrials.Veeva

Menu

Multicenter Study to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP)

P

Pakistan Institute of Living and Learning

Status

Completed

Conditions

Self Harm

Treatments

Behavioral: Culturally adapted therapy (C-MAP)

Study type

Interventional

Funder types

Other

Identifiers

NCT02742922
PILL-CMAP-001

Details and patient eligibility

About

To evaluate the clinical and cost-effectiveness of a culturally adapted therapy (C-MAP) in patients with a history of self-harm

Full description

Suicide is a serious global public health issue, ranked amongst the leading causes of death in many countries. Most of these (75%) are in the low and middle income countries (LAMIC) and globally suicide is the second leading cause of death in young people 15-29 years of age. There is no official data on suicide from Pakistan, a conservative South Asian Islamic country with historically low suicide rates. Both suicide and attempted suicide are illegal acts, as well as socially and religiously condemned, however, there is accumulating evidence that suicide rates have been gradually increasing in Pakistan over the last few years.

The culturally adapted psychological intervention C-MAP utilizes problem solving components within a brief intervention that can be widely utilized in clinical practice. Our previous pilot trial in Karachi shows the efficacy of CBT based intervention(C-MAP) in people who had recently self harmed.The findings from this work have highlighted the applicability of such an intervention to health services in Pakistan for patients who present after a self-harm episode

Enrollment

901 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients over the age of 18 years will be considered eligible for the study.
  2. Participants will have to be living within the catchment area of the participating practices and hospitals.
  3. Not needing inpatient psychiatric treatment.

Exclusion criteria

  1. Temporary resident unlikely to be available for follow up.
  2. Participants with ICD-I0 mental disorder; due to a general medical condition or substance misuse, dementia, delirium, alcohol or drug dependence, schizophrenia, bipolar disorder, learning disability.
  3. Unable to engage, participate or respond to the research questionnaires.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

901 participants in 2 patient groups

Culturally adapted therapy (C-MAP)
Experimental group
Description:
Culturally adapted manual assisted (C-MAP) brief problem solving therapy
Treatment:
Behavioral: Culturally adapted therapy (C-MAP)
Treatment as usual
No Intervention group
Description:
This arm will receive no intervention only TAٓU.

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems